Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

BUY
$31.15 - $33.39 $1,027 - $1,101
33 Added 0.72%
4,634 $0
Q4 2021

Feb 01, 2022

BUY
$17.46 - $21.61 $2,217 - $2,744
127 Added 2.84%
4,601 $94,000
Q3 2021

Oct 15, 2021

BUY
$17.35 - $22.5 $1,717 - $2,227
99 Added 2.26%
4,474 $86,000
Q1 2021

May 07, 2021

SELL
$19.76 - $29.89 $5,928 - $8,967
-300 Reduced 6.42%
4,375 $115,000
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $1.1 Million - $1.51 Million
-69,700 Reduced 93.71%
4,675 $87,000
Q2 2020

Aug 05, 2020

SELL
$7.84 - $23.29 $557,463 - $1.66 Million
-71,105 Reduced 48.88%
74,375 $1.73 Million
Q1 2020

May 05, 2020

SELL
$5.57 - $11.5 $145,521 - $300,449
-26,126 Reduced 15.22%
145,480 $1.22 Million
Q4 2019

Feb 14, 2020

BUY
$7.9 - $10.14 $19,750 - $25,350
2,500 Added 1.48%
171,606 $1.68 Million
Q2 2019

Aug 07, 2019

BUY
$10.88 - $17.6 $312,179 - $504,996
28,693 Added 20.43%
169,106 $2.01 Million
Q1 2019

May 14, 2019

BUY
$15.51 - $17.61 $216,643 - $245,976
13,968 Added 11.05%
140,413 $2.47 Million
Q3 2018

Nov 14, 2018

SELL
$14.85 - $16.35 $6,133 - $6,752
-413 Reduced 0.33%
126,445 $1.88 Million
Q2 2018

Aug 14, 2018

SELL
$13.8 - $16.8 $685,032 - $833,952
-49,640 Reduced 28.12%
126,858 $2.02 Million
Q1 2018

May 15, 2018

SELL
$13.8 - $16.2 $1.38 Million - $1.62 Million
-100,000 Reduced 36.17%
176,498 $2.51 Million
Q3 2017

Nov 14, 2017

BUY
$13.45 - $14.35 $801,552 - $855,188
59,595 Added 27.48%
276,498 $3.95 Million
Q2 2017

Aug 11, 2017

BUY
N/A
216,903
216,903 $3.42 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.